We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Matt Birnholz, MD
Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?
Anish Patel, DO, FACG
Real-World Pattern of Biologic Use in Patients with Inflammatory Bowel Disease
Jay L. Koyner, MD
Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
John A. Kellum, MD, MCCM
Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?
Maurice Pickard, MD
Bottles of Lies: The Inside Story of the Generic Drug Boom
Wes Ely, MD, MPH
Delirium: The Hidden Disorder Plaguing ICU Patients
Mario R. Nacinovich, Jr., MSc
Zachary Palace, MD, CMD, FACP
Facts, Myths, & Misconceptions of Medical Marijuana
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
John J. Russell, MD
Meredith Wadman, BM, BCh, M.S.
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
Updates in the Management of Early Alzheimer’s Disease
You need to be logged in to save this episode to a playlist.
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education